文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

一种捕获抗原特异性高亲和力B细胞的微流控策略。

A Microfluidic Strategy to Capture Antigen-Specific High-Affinity B Cells.

作者信息

Alhassan Ahmed M, Shirure Venktesh S, Luo Jean, Nguyen Bryan B, Rollins Zachary A, Shergill Bhupinder S, Zhu Xiangdong, Baumgarth Nicole, George Steven C

机构信息

Department of Biomedical Engineering University of California Davis CA 95616 USA.

Department of Pathology, Microbiology, and Immunology University of California Davis CA 95616 USA.

出版信息

Adv Nanobiomed Res. 2024 Jun;4(6):2300101. doi: 10.1002/anbr.202300101. Epub 2024 Apr 26.


DOI:10.1002/anbr.202300101
PMID:40585897
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12203763/
Abstract

Assessing B cell affinity to pathogen-specific antigens prior to or following exposure could facilitate the assessment of immune status. Current standard tools to assess antigen-specific B cell responses focus on equilibrium binding of the secreted antibody in serum. These methods are costly, time-consuming, and assess antibody affinity under zero force. Recent findings indicate that force may influence BCR-antigen binding interactions and thus immune status. Herein, a simple laminar flow microfluidic chamber in which the antigen (hemagglutinin of influenza A) is bound to the chamber surface to assess antigen-specific BCR binding affinity of five hemagglutinin-specific hybridomas from 65 to 650 pN force range is designed. The results demonstrate that both increasing shear force and bound lifetime can be used to enrich antigen-specific high-affinity B cells. The affinity of the membrane-bound BCR in the flow chamber correlates well with the affinity of the matched antibodies measured in solution. These findings demonstrate that a microfluidic strategy can rapidly assess BCR-antigen-binding properties and identify antigen-specific high-affinity B cells. This strategy has the potential to both assess functional immune status from peripheral B cells and be a cost-effective way of identifying individual B cells as antibody sources for a range of clinical applications.

摘要

在接触病原体之前或之后评估B细胞对病原体特异性抗原的亲和力,有助于评估免疫状态。当前评估抗原特异性B细胞反应的标准工具主要关注血清中分泌抗体的平衡结合。这些方法成本高、耗时,且是在零力条件下评估抗体亲和力。最近的研究结果表明,力可能会影响BCR-抗原结合相互作用,进而影响免疫状态。在此,设计了一种简单的层流微流控腔室,将抗原(甲型流感病毒血凝素)结合到腔室表面,以在65至650 pN的力范围内评估来自5种血凝素特异性杂交瘤的抗原特异性BCR结合亲和力。结果表明,增加剪切力和结合寿命均可用于富集抗原特异性高亲和力B细胞。流动腔室中膜结合BCR的亲和力与溶液中测得的匹配抗体的亲和力密切相关。这些发现表明,微流控策略可以快速评估BCR-抗原结合特性,并识别抗原特异性高亲和力B细胞。该策略既有潜力从外周B细胞评估功能性免疫状态,又有可能成为一种经济有效的方法,用于识别个体B细胞作为一系列临床应用的抗体来源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ecb/12203763/e41b98a1cfa8/ANBR-4-0-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ecb/12203763/196270f7ecb5/ANBR-4-0-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ecb/12203763/26ecddad4b5c/ANBR-4-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ecb/12203763/1e984dcf56db/ANBR-4-0-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ecb/12203763/0c5d311586b6/ANBR-4-0-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ecb/12203763/18cd7f33526c/ANBR-4-0-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ecb/12203763/e41b98a1cfa8/ANBR-4-0-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ecb/12203763/196270f7ecb5/ANBR-4-0-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ecb/12203763/26ecddad4b5c/ANBR-4-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ecb/12203763/1e984dcf56db/ANBR-4-0-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ecb/12203763/0c5d311586b6/ANBR-4-0-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ecb/12203763/18cd7f33526c/ANBR-4-0-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ecb/12203763/e41b98a1cfa8/ANBR-4-0-g004.jpg

相似文献

[1]
A Microfluidic Strategy to Capture Antigen-Specific High-Affinity B Cells.

Adv Nanobiomed Res. 2024-6

[2]
A microfluidic strategy to capture antigen-specific high affinity B cells.

bioRxiv. 2023-7-14

[3]
Systemic treatments for metastatic cutaneous melanoma.

Cochrane Database Syst Rev. 2018-2-6

[4]
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.

Cochrane Database Syst Rev. 2022-5-20

[5]
Management of urinary stones by experts in stone disease (ESD 2025).

Arch Ital Urol Androl. 2025-6-30

[6]
Antibody tests for identification of current and past infection with SARS-CoV-2.

Cochrane Database Syst Rev. 2022-11-17

[7]
Interventions targeted at women to encourage the uptake of cervical screening.

Cochrane Database Syst Rev. 2021-9-6

[8]
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

Health Technol Assess. 2006-9

[9]
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.

Health Technol Assess. 2001

[10]
Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis.

Health Technol Assess. 2024-7

本文引用的文献

[1]
Mechanical forces impair antigen discrimination by reducing differences in T-cell receptor/peptide-MHC off-rates.

EMBO J. 2023-4-3

[2]
Receptor-ligand non-equilibrium kinetics (RLNEK) 1.0: An integrated Trackmate laminar flow chamber analysis.

J Immunol Methods. 2022-12

[3]
Simultaneous affinity maturation and developability enhancement using natural liability-free CDRs.

MAbs. 2022

[4]
Monoclonal antibody therapies against SARS-CoV-2.

Lancet Infect Dis. 2022-11

[5]
Microfluidic T Cell Selection by Cellular Avidity.

Adv Healthc Mater. 2022-8

[6]
Pre-exposure prophylaxis with 300 mg Evusheld elicits limited neutralizing activity against the Omicron variant.

Kidney Int. 2022-8

[7]
Rapid isolation of antigen-specific B-cells using droplet microfluidics.

RSC Adv. 2020-7-20

[8]
Germinal Centers.

Annu Rev Immunol. 2022-4-26

[9]
Mini-review: The market growth of diagnostic and therapeutic monoclonal antibodies - SARS CoV-2 as an example.

Hum Antibodies. 2022

[10]
Discovery and characterization of high-affinity, potent SARS-CoV-2 neutralizing antibodies via single B cell screening.

Sci Rep. 2021-10-20

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索